Log In
Print this Print this

ConZip, Durela, tramadol extended-release (formerly Cip-tramadol ER)

  Manage Alerts
Collapse Summary General Information
Company Galephar Pharmaceutical Research Inc.
DescriptionOnce-daily sustained-release formulation of tramadol
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat moderate to moderately severe chronic pain; Treat pain
Regulatory Designation
PartnerAralez Pharmaceuticals Inc.;
Cipher Pharmaceuticals Inc.;
Vertical Pharmaceuticals LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today